Seroprevalencija arbovirusnih infekcija kod pripadnika mirovnih misija Ujedinjenih nacija u Centralnoafričkoj Republici
Sažetak
Uvod/Cilј. Pripadnici Vojske Srbije koji učestvuju u Multinacionalnoj operaciji Ujedinjenih nacija (UN) u Centralnoafričkoj Republici (CAR) – MINUSCA, izloženi su tokom boravka u misiji ubodima komaraca roda Aedes koji su prenosioci nekih (ili pojedinih) arbovirusa. Cilj rada bio je da se utvrdi izloženost, faktori rizika i mere prevencije i zaštite od infekcije arbovirusima kod pripadnika mirovnih misija. Metode. U studiju je uključeno 136 pripadnika mirovnih operacija UN u CAR iz dve rotacije tokom 2022/2023 godine u trajanju od 8 i 6 meseci. Svaki ispitanik morao je da odgovori na pitanja koja su data u dizajniranom epidemiološkom upitniku za povratnike iz mirovnih misija. Krvni serumi ispitanika testirani su enzyme-linked immunosorbent assay (ELISA) testom na prisustvo specifičnih antitela na viruse Dengue, Zika i Chikungunya. Rezultati. Utvrđeno je 48 (35,3%) seropozitivnih ispitanika na arboviruse. Najviše seropozitivnih pripadnika, 23 (16,9%), bilo je na Dengue virus, nešto manje na Chikungunya virus, 14 (10,3%), dok je najmanje bilo pozitivno na Zika virus, 11 (8,1%). Naše istraživanje pokazuje da impregnacija uniforme repelentom ima značajnu ulogu u prevenciji uboda komaraca i sprečavanju infekcije Zika virusom. Broj dana provedenih u misiji, kao i faktor pola i godine starosti nisu pokazali uticaj na pojavu infekcija arbovirusom. Zaklјučak. Pripadnici mirovnih misija u CAR došli su u kontakt sa virusima Dengue, Zika i Chikungunya. To ukazuje da je neophodno raditi na stalnom unapređenju mera prevencije i zaštite njihovog zdravlјa, uklјučujući serološka ispitivanja, ali i ispitivanja prisustva različitih infektivnih mikroorganizama tog endemskog područja.
Reference
Maia LJ, Oliveira CH, Silva AB, Souza PAA, Müller NFD, Car-doso JDC, et al. Arbovirus surveillance in mosquitoes: Histori-cal methods, emerging technologies, and challenges ahead. Exp Biol Med 2023; 248(22): 2072−82.
Santos LLM, de Aquino EC, Fernandes SM, Ternes YMF, Feres VCR. Dengue, chikungunya, and Zika virus infections in Lat-in America and the Caribbean: a systematic review. Rev Panam Salud Publica 2023; 47: e34.
Cortes N, Lira A, Prates-Syed W, Dinis Silva J, Vuitika L, Ca-bral-Miranda W, et al. Integrated control strategies for dengue, Zika, and Chikungunya virus infections. Front Immunol 2023; 14: 1281667.
Kok BH, Lim HT, Lim CP, Lai NS, Leow CY, Leow CH. Den-gue virus infection - a review of pathogenesis, vaccines, diag-nosis and therapy. Virus Res 2023; 324: 199018.
Tayal A, Kabra SK, Lodha R. Management of Dengue: An Up-dated Review. Indian J Pediatr 2023; 90(2): 168–77.
Bhandari V, Taksande AB, Sapkale B. Disease Transmission and Diagnosis of Zika Virus. Cureus 2023; 15(11): e49263.
Giraldo MI, Gonzalez-Orozco M, Rajsbaum R. Pathogenesis of Zika virus infection. Annu Rev Pathol 2023; 18(1): 181–203.
Bartholomeeusen K, Daniel M, LaBeaud DA, Gasque P, Peeling RW, Stephenson KE, et al. Chikungunya fever. Nat Rev Dis Primers 2023; 9(1): 17. Erratum in: Nat Rev Dis Primers 2023; 9(1): 26.
De Lima Cavalcanti TYV, Pereira MR, de Paula SO, Franca RFO. A Review on Chikungunya Virus Epidemiology, Patho-genesis and Current Vaccine Development. Viruses 2022; 14(5): 969.
Cai L, Hu X, Liu S, Wang L, Lu H, Tu H, et al. The research progress of Chikungunya fever. Front Public Health 2023; 10: 1095549.
Soni S, Gill VJS, Anusheel, Singh J, Chhabra J, Gill GJS, et al. Dengue, Chikungunya, and Zika: The Causes and Threats of Emerging and Re-emerging Arboviral Diseases. Cureus 2023; 15(7): e41717.
Beckham JD, Tyler KL. Arbovirus Infections. Continuum (Minneap Minn) 2015; 21(6 Neuroinfectious Disease): 1599–611.
Huang Z, Zhang Y, Li H, Zhu J, Song W, Chen K, et al. Vaccine development for mosquito-borne viral diseases. Front Immu-nol 2023; 14: 1161149.
Evans-Gilbert T. Vertically transmitted chikungunya, Zika and dengue virus infections: The pathogenesis from mother to fe-tus and the implications of co-infections and vaccine devel-opment. Int J Pediatr Adolesc Med 2020; 7(3): 107–11.
Achee NL, Grieco JP, Vatandoost H, Seixas G, Pinto J, Ching-Ng L, et al. Alternative strategies for mosquito-borne arbovirus control. PLoS Negl Trop Dis 2019; 13(1): e0006822. Erra-tum in: PLoS Negl Trop Dis 2019; 13(3): e0007275.
Tsalefac M, Hiol FH, Mahe G, Laraque A, Sonwa D, Scholte P, et al. Climate of Central Africa: past, present and future. In: De Wasseige C, Tadoum M, Eba'a Atyi R, Doumenge C, editors. The Forests of the Congo Basin - Forests and climate change. Belgium: Weyrich; 2015. p. 37–52.
Massengo NRB, Tinto B, Simonin Y. One Health Approach to Arbovirus Control in Africa: Interests, Challenges, and Diffi-culties. Microorganisms 2023; 11(6): 1496.
Hesse EM, Martinez LJ, Jarman RG, Lyons AG, Eckels KH, De La Barrera RA, et al. Dengue Virus Exposures Among De-ployed U.S. Military Personnel. Am J Trop Med Hyg 2017; 96(5): 1222–6.
Adam A, Seidahmed OM, Weber C, Schnierle B, Schmidt-Chanasit J, Reiche S, et al. Low Seroprevalence Indicates Vulnerability of Eastern and Central Sudan to Infection with Chikungunya Virus. Vector Borne Zoonotic Dis 2016; 16(4): 290–1.
Gilbert DN, Moore WL Jr, Hedberg CL, Sanford JP. Potential medical problems in personnel returning from Vietnam. Ann Intern Med 1968; 68(3): 662–78.
Frickmann H, Herchenröder O. Chikungunya Virus Infections in Military Deployments in Tropical Settings-A Narrative Mini-review. Viruses 2019; 11(6): 550.
Sugiharto VA, Widjaja S, Hartman LJ, Williams M, Myers TE, Simons MP. Zika virus surveillance in active-duty U.S. military and dependents through the Naval Infectious Diseases Diag-nostic Laboratory. MSMR 2019; 26(7): 18–23.
Varghese J, De Silva I, Millar DS. Latest Advances in Arbo-virus Diagnostics. Microorganisms 2023; 11(5): 1159.
Haldar I, Kulkarni V, Jangale N, Putta S. Increased chikungunya seropositivity with Dengue co-infection-trend in recent years. J Cardiovasc Dis Res 2023; 14(4): 1–6.
Kajeguka DC, Msonga M, Schioler KL, Meyrowitsch DW, Syrianou P, Tenu F, et al. Individual and environmental risk factors for dengue and chikungunya seropositivity in North-Eastern Tan-zania. Infect Dis Health 2017; 22(2): 65–76.
Pages F, Faulde M, Orlandi-Pradines E, Parola P. The past and present threat of vector-borne diseases in deployed troops. Clin Microbiol Infect 2010; 16(3): 209–24.
Pollett S, Kuklis CH, Barvir DA, Jarman RG, Romaine RM, For-shey BM, et al. The seroepidemiology of dengue in a US mili-tary population based in Puerto Rico during the early phase of the Zika pandemic. PLoS Negl Trop Dis 2022; 16(1): e0009986.
Broban A, Olive MM, Tantely ML, Dorsemans AC, Rakotomanana F, Ravalohery JP, et al. Seroprevalence of IgG Antibodies Di-rected against Dengue, Chikungunya and West Nile Viruses and Associated Risk Factors in Madagascar, 2011 to 2013. Vi-ruses 2023; 15(8): 1707.